AdaptHealth Corp. (NASDAQ:AHCO) Shares Sold by Russell Investments Group Ltd.

Russell Investments Group Ltd. lowered its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 15.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 195,171 shares of the company's stock after selling 34,982 shares during the quarter. Russell Investments Group Ltd. owned 0.15% of AdaptHealth worth $1,858,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Pacer Advisors Inc. purchased a new stake in shares of AdaptHealth in the fourth quarter valued at approximately $76,271,000. Principal Financial Group Inc. raised its position in shares of AdaptHealth by 204.0% in the 4th quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company's stock valued at $15,735,000 after purchasing an additional 1,109,021 shares during the last quarter. Segall Bryant & Hamill LLC increased its stake in shares of AdaptHealth by 29.8% in the fourth quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company's stock worth $45,734,000 after acquiring an additional 1,102,173 shares during the period. Geode Capital Management LLC grew its position in AdaptHealth by 12.2% during the 3rd quarter. Geode Capital Management LLC now owns 2,451,173 shares of the company's stock worth $27,532,000 after purchasing an additional 265,712 shares during the period. Finally, Royce & Associates LP raised its stake in shares of AdaptHealth by 29.0% during the 4th quarter. Royce & Associates LP now owns 1,002,755 shares of the company's stock valued at $9,546,000 after buying an additional 225,350 shares during the last quarter. Hedge funds and other institutional investors own 82.67% of the company's stock.

AdaptHealth Trading Up 3.8 %

Shares of NASDAQ:AHCO traded up $0.29 during trading on Thursday, reaching $8.02. The stock had a trading volume of 200,537 shares, compared to its average volume of 1,496,667. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.90. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The business has a fifty day moving average price of $9.61 and a 200-day moving average price of $9.91. The stock has a market cap of $1.08 billion, a P/E ratio of -4.86, a PEG ratio of 1.08 and a beta of 1.44.

Wall Street Analyst Weigh In

Several research firms recently commented on AHCO. Truist Financial raised their target price on AdaptHealth from $12.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Canaccord Genuity Group lifted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Royal Bank of Canada increased their price objective on AdaptHealth from $11.00 to $14.00 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Robert W. Baird increased their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Thursday, February 27th. Finally, UBS Group decreased their price objective on shares of AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, February 13th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $13.80.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.